Juno Therapeutics Company

Juno Therapeutics is a clinical-stage company, develops immunotherapies for the treatment of cancer.
Industry: CAR-T
Headquarters: Seattle, Washington, United States
Founded Date: 2013-01-01
Employees Number: 251-500
Funding Status: M&A
Investors Number: 4
Total Funding: 310000000
Estimated Revenue: $100M to $500M
Last Funding Date: 2014-08-05
Last Funding Type: Series B

Visit Website
Info@junotherapeutics.com
Register and Claim Ownership